Articles tagged with Kinase Activity
A new study has discovered a crucial protein interaction that controls the photosynthetic machinery in plants. The discovery sheds light on how plants adapt to changes in light conditions and balance the light-harvesting capacities of both photosystems, enabling efficient energy transformation.
Researchers found that condensing into droplets optimizes biochemical conditions for kinases to catalyze reactions and activate cell signaling pathways. This phenomenon helps control growth signals and could lead to new strategies for cancer drug development by interfering with the ability of enzymes to form droplets.
Researchers have discovered that the CCDC6-RET protein can activate itself, accelerating its function and making it a promising target for cancer therapy. The study also reveals a new mechanism of action, where the protein can utilize both ATP and ADP as energy sources.
The review highlights LRRK2's diverse cellular functions and pathogenic mechanisms in various diseases, including Parkinson's disease and inflammatory disorders. Therapeutic strategies targeting LRRK2, such as kinase inhibitors and emerging approaches like PROTACs and gene therapy, show promise for correcting cellular imbalances and re...
Researchers have discovered that dialing down sugar metabolism can break down neural integrity, but manipulating this process can also activate protective programs in neurons. Two proteins, DLK and SARM1, are involved in extending axon health, with their activity influenced by the cell's internal conditions.
A newly developed AI-based tool uses protein expression to create a stemness index that analyzes tumor similarity to pluripotent stem cells. The model predicts tumor aggressiveness and identifies potential targets for new therapies, offering hope for improved cancer treatment.
A recent study published in the Journal of Ageing and Physical Activity found that older adults exhibit similar or even less muscle damage than young adults after exercise. Muscle soreness was consistently lower in older adults, with reductions of around 34% at 48 hours and 62% at 72 hours compared to younger individuals.
A study reveals that protein kinase A promotes wakefulness, while protein phosphatase 1 and calcineurin promote sleep in mammals. The balance between sleep and wakefulness is regulated by multiple enzymes, including PKA, PP1, and calcineurin.
Researchers identified a protein called Casein Kinase 1 delta (CK1δ) that regulates our biological clock by tagging other proteins to fine-tune circadian rhythms. The discovery highlights how a small part of CK1δ can greatly influence its overall activity, opening new avenues for treating disorders related to the body clock.
Research shows that parvalbumin-expressing neurons in the cerebral cortex activate when sleepiness increases, leading to rebound sleep. The activation of CaMKII protein causes rebound sleep by activating these neurons. This study sheds light on the molecular and neural mechanisms of sleep homeostasis.
Researchers found that lithium's efficacy in enhancing longevity and altering body composition is influenced by the sucrose content of the diet. The study reveals a significant overlap between the transcriptional responses to increasing dietary sucrose and adding lithium, suggesting a joint mechanism at play.
A recent study published in The Open Sports Sciences Journal found that Ascorbic acid supplementation reduced exercise-induced oxidative stress and inflammation in healthy women. The supplement also increased plasma ascorbic acid levels and reduced post-exercise MDA levels, suggesting a potential protective effect against muscle injury.
Scientists at Sanford Burnham Prebys and Vanderbilt University have identified phosphatidylinositol-5-phosphate 4-kinases (PI5P4Ks) as a key regulator of the hippo pathway, which is dysregulated in cancer. The study suggests that targeting PI5P4Ks may lead to new treatments for cancers with abnormal hippo signaling.
Researchers will develop new tools to understand how proteins interact and regulate the nervous system. The project aims to identify new therapeutic targets for brain disorders and generate diagnostic tools.
Researchers at Nagoya University have discovered a relationship between ALS progression and the disruption of mitochondria-associated membranes (MAM) and TBK1 activity. Decreased activation of TBK1 is linked to motor neuron death in ALS patients and mice with disrupted MAM.
GFH009 inhibits tumor growth and induces apoptosis in various HHM-derived cell lines. The compound's mechanism of action involves rapid 'on-off' inhibition of CDK9, which exerts a proapoptotic effect on cancer cells.
The study identifies FAM53C as a cytosolic-anchoring inhibitory binding protein of the kinase DYRK1A, regulating its activity and cellular location. This finding may provide potential clinical insights into treating Down syndrome and related diseases.
A new study published in Exp. Mol. Med. has identified Thrap3 as a key player in exacerbating non-alcoholic fatty liver disease (NAFLD) by inhibiting AMPK, a crucial regulator of fat metabolism. Inhibiting Thrap3 expression presents a promising avenue for treating NAFLD.
Researchers explore kinase inhibitors as targeted therapies for specific CRC subsets, offering hope for improved treatment options. Key findings suggest that uncovering essential kinases for tumor growth can lead to more effective treatment strategies in metastatic or later-stage CRC patients.
Researchers from Universitat de Barcelona and Universitat Internacional de Catalunya discuss the non-receptor protein tyrosine kinase Src as a good example of an oncogene. Targeting the Src N-terminal regulatory element (SNRE) has potential as oncotargets to inhibit Src activity only in cancer cells.
Researchers found that gatekeeper mutations in kinases can destabilize the inactive form, making them more active and prone to cancer recurrence. This could inform which drugs oncologists use as a first-line treatment.
A new study from the University of Tsukuba identifies a critical signaling pathway within brain cells that regulates both the length and depth of sleep. By manipulating enzymes and proteins, researchers found that altering this pathway can significantly impact sleep duration and quality.
Researchers identified differences in PTK activity between normal and cancer kidney tissue, with Src family kinases and PI3K pathways exhibiting high activity. Ex vivo treatment of clear cell RCC with TKIs revealed that tivozanib and cabozantinib were more potent inhibitors than sunitinib or pazopanib.
Researchers from the US and Japan have discovered the mechanism of GTP recognition by a tumor-promoting kinase, leading to the evolution of a GTP sensor kinase. This finding could lead to the development of a new cancer-treating drug that targets PI5P4Kβ using GTP instead of ATP.
Researchers at Purdue University discovered that some lung cancer patients become resistant to common therapeutics due to epigenetic regulation of the KMT5C gene. This understanding lays the groundwork for future therapeutics and provides insight into the biology and progression of cancers.
The study found that all 86 tridomain homologues of NDP-heptose synthetases are conserved in Actinobacteria, with three types of gene clusters encoding different natural products. The kinase domains of four selected proteins were found to be dysfunctional.
MUSC researcher Haizhen Wang receives R37 grant to investigate CDK6's role in T-cell acute lymphoblastic leukemia, a aggressive cancer. The research aims to understand how the immune system can be used to reduce leukemia progression.
Researchers at UC San Diego developed a new nanosensor, SNACS, to monitor SnRK2 protein kinase activity in live plant cells. This allows for the study of drought tolerance mechanisms in unprecedented detail, providing insights into how plants respond to environmental stress.
Researchers discovered an alternate mechanism by which the molecule RIPK1 triggers cell death in infected or damaged cells. The finding breaks existing dogma that RIPK1 kinase activity is required for cell death and holds promise for treating inflammatory diseases and cancer.
A new compound developed at the University of Toronto Scarborough can monitor protein kinase activity without using radioactive isotopes. This innovation has potential to improve cancer treatment by providing a safer and more accurate method for assessing drug effectiveness.
Researchers have developed a new technique to observe and report on the behavior of kinase signaling proteins in living cells. This allows for the tracking of multiple kinases functioning in living cells, enabling the observation of healthy versus diseased cell comparison and experimental drug effects.
Researchers at the Gladstone Institutes found that mutant LRRK2 accumulation leads to cell death in Parkinson's neurons, and that alpha-synuclein plays a crucial role in this process. By understanding the interplay between these two proteins, scientists may develop new therapeutic strategies to target the disease's underlying mechanisms.
Researchers generated a novel kinase-dead mutant mouse of the CaMKII alpha gene that lacks its kinase activity, leading to severe deficits in hippocampal synaptic plasticity and behavioral learning. The findings support the idea that CaMKII alpha kinase activity is essential for memory functions.
Researchers found that EGFR stabilizes sodium/glucose transporter 1 to maintain adequate glucose levels in cancer cells, preventing autophagic cell death. This study suggests that inhibiting both EGFR-mediated SGLT1 stabilization and EGFR kinase activity may be necessary for eradicating epithelial tumors.